HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated a Neutral rating on Zymeworks (NASDAQ:ZYME) and maintained a $10 price target, indicating no expected short-term price movement.
September 18, 2024 | 11:07 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a Neutral rating on Zymeworks and maintained a $10 price target, suggesting no expected short-term price movement.
The reiteration of a Neutral rating and maintenance of the $10 price target by HC Wainwright & Co. suggests that the analyst does not foresee any significant short-term changes in Zymeworks' stock price. This indicates stability rather than a positive or negative movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100